Medical Specialty >> Pharmacy
AHA: Taking Medicine for a Cold? Be Mindful of Your Heart
12:00 PM CST.
Read article
- Big Pharma’s Marketing to Docs Helped Trigger Opioid Crisis: Study
- Opioid Prescriptions Almost Twice as Likely for Rural vs. Urban Americans
- Opioid Use in Pregnancy Tied to Severe Birth Defects
- When Your Medications Are the News
JOURNAL UPDATE
Medication Treatment for Substance Abuse Up in Facilities
7:00 PM CST. 2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016- Inappropriate Antibiotic Rx Common in Privately Insured
- Oral Hepatoselective Glucokinase Activator Promising in T2DM
- Mandated Neonatal Abstinence Reporting Helps Quantify Cases
MONTHLY JOURNAL SUMMARY
December 2018 Briefing - Pharmacy
January 02, 2019. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
